Three pharma groups have opened a new front in their legal challenge to the federal 340B drug pricing programme in the US, trying to limit some of the steep discounts it offers on drugs provided to ...
A kidney transplant patient with a rare, multidrug-resistant (MDR) infection has become the first to be treated using an adjunctive bacteriophage therapy developed by Denmark's SNIPR Biome. The ...
For forty years, fitness was sold as a promise of appearance. That promise has lost its grip. The market is now organising around a different proposition: live longer, live better, stay functional.
For connected devices in particular, two challenges have stood out: Global reach was costly. Smaller satellite-connected ...
The US regulator has sent a complete response letter (CRL) to Germany-based ITM, saying there are deficiencies in its chemistry, manufacturing and controls (CMC) in its New Drug Application (NDA) for ...
England is one of a handful of countries globally to have already exceeded the WHO benchmark of treating 80% of all known ...
The approval makes the UK the first country in Europe to approve Foundayo (orforglipron), which becomes only the second product in the oral GLP-1 class to be cleared for use by the MHRA after Novo ...
Henry Gosebruch, pictured here during his time at Neumora, is replacing Paul Stoffels as CEO of Galapagos. Just a few months after announcing a plan to separate its drug and cell therapy businesses ...
The FDA has approved AbbVie's Decnupaz, a treatment for rare blood cancer blastic plasmacytoid dendritic cell neoplasm (BPDCN) that was one of the assets in its $10.1 billion takeover of ImmunoGen in ...
Dame Emma Walmsley has been CEO at GSK since 2017. This week has kicked off with the unexpected news that Emma Walmsley is standing down as chief executive of GSK after eight years, to be replaced by ...
Ex-BioNTech chief strategy officer Ryan Richardson is chief executive of the new outfit, which launches with $25 million in ...
US President Donald Trump has signed an executive order that rips up the current US policy on childhood immunisations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results